Market Overview

The global blood collection market trends, valued at USD 7.26 billion in 2024, is expected to reach USD 10.36 billion by 2033, growing at a 4.03% CAGR. This expansion is driven by rising healthcare demand, increasing prevalence of chronic diseases, innovations in minimally invasive tools, and robust funding in diagnostics—making blood collection more precise, accessible, and patient-friendly.

Study Assumption Years

• Base Year: 2024
• Historical Year: 2019–2024
• Forecast Year: 2025–2033

Blood Collection Market Key Takeaways

• North America leads, holding ~41.2% market share in 2024.
• The blood collection market size was USD 7.26 B in 2024 and is forecast to reach USD 10.36 B by 2033 at a 4.03% CAGR.
• Product segmentation: Needles & syringes, blood collection tubes (serum‑separating, EDTA, heparin, plasma‑separating), blood bags, and others.
• By application: Diagnostics (≈66.7%), driven by early and precise testing; treatment also contributes.
• End use: Hospitals dominate (~37.2%), followed by diagnostic centres, blood banks, and others.
• Key market drivers include chronic diseases, aging populations, rapid surgical growth, and technological innovation.

Market Growth Factors

Rising Prevalence of Chronic and Infectious Diseases

One of the strongest drivers of the blood collection market is the rising prevalence of chronic conditions such as cancer, diabetes, and cardiovascular diseases, alongside infectious diseases like HIV, hepatitis, and emerging viral outbreaks. These conditions require regular blood tests for accurate diagnosis, monitoring, and treatment planning. The global healthcare system is increasingly dependent on blood-based diagnostics, as they provide quick and precise insights into a patient’s health. Furthermore, periodic blood collection is vital in tracking disease progression and treatment response. As chronic diseases continue to expand worldwide due to aging populations, sedentary lifestyles, and urbanization, the demand for blood collection products, including tubes, needles, and devices, is expected to increase substantially. This trend highlights the essential role of blood collection in preventive and personalized medicine, ultimately supporting sustained market growth.

Growth in Diagnostic Testing and Laboratory Services

The blood collection market is expanding rapidly due to the rising number of diagnostic tests being conducted globally. With the growing emphasis on preventive healthcare, individuals are opting for regular health check-ups, many of which rely on blood samples for accurate results. Advanced laboratory services now require highly efficient blood collection systems to handle large testing volumes with precision. In addition, the global rise in diagnostic centers and hospitals has created significant demand for consumables such as vacutainers, syringes, and safety blood collection sets. Emerging economies are also investing heavily in modernizing laboratory infrastructure, further propelling growth. Technological innovations in automated blood analyzers and point-of-care testing also rely on high-quality blood collection methods. This increased focus on laboratory efficiency and test accuracy has made reliable blood collection products indispensable, creating a steady demand trajectory for manufacturers in this sector.

Increasing Demand for Blood Donations and Transfusions

Another key factor driving the blood collection market is the global demand for blood donations and transfusions. Blood is essential for emergency medical care, trauma cases, maternal health, surgical procedures, and the management of conditions like anemia and blood-related cancers. With road accidents, natural disasters, and surgical procedures rising globally, blood transfusions remain a critical part of healthcare delivery. Moreover, national and international health organizations are consistently conducting awareness campaigns to encourage voluntary blood donations. This has boosted the demand for advanced blood collection bags, donor management systems, and safety equipment. Additionally, innovations in blood storage and preservation technologies have made transfusion services more reliable and efficient. As healthcare providers continue to strengthen blood banks and transfusion centers, the need for safe, sterile, and efficient blood collection methods is expected to rise steadily.

Request for a sample copy of this report: https://www.imarcgroup.com/blood-collection-market/requestsample

Market Segmentation

• By Product:
• Needles and Syringes
• Blood Collection Tubes
• Serum-separating
• EDTA
• Heparin
• Plasma-separating
• Blood Bags
• Others
• By Application:
• Diagnostics
• Treatment
• By End Use:
• Hospitals
• Diagnostics Centers
• Blood Banks
• Others
• Breakup By Region:

• North America (United States, Canada)

• Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)

• Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)

• Latin America (Brazil, Mexico, Others)

• Middle East and Africa

Regional Insights

North America is leading the way with a significant 41.2% market share, primarily driven by the U.S. The region benefits from a robust healthcare infrastructure, a high prevalence of chronic diseases like diabetes, cardiovascular issues, and cancer, along with a strong embrace of automated diagnostics, all of which fuel growth. Additionally, government initiatives and a culture that encourages blood donation further solidify North America's position at the forefront.

Recent Developments & News

Recent advancements include the 2024 launch of the ICHOR line by Husky Technologies and Kriya Medical in India, which has the capacity to produce an impressive 250 million blood tubes each year. Meanwhile, BD has expanded its partnership with Babson Diagnostics to facilitate home-based blood collection, enhancing the shift towards decentralized, patient-focused diagnostics. On a global scale, capillary point-of-care tools that prioritize safety are becoming increasingly popular, such as Terumo’s devices in the Asia-Pacific region and BD’s MiniDraw in the U.S.

Key Players

• Abbott Laboratories
• Becton Dickinson and Company
• FL MEDICAL s.r.l.
• Greiner AG
• Haemonetics Corporation
• McKesson Corporation
• Medtronic plc
• Nipro Corporation
• Qiagen N.V.
• Quest Diagnostics
• Sarstedt AG & Co. KG
• Terumo Corporation

Ask Analyst for Customization:  https://www.imarcgroup.com/request?type=report&id=4975&flag=C

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us:

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provides a comprehensive suite of market entry and expansion services. IMARC offerings include a thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape, and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us: 

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: sales@imarcgroup.com

Tel No: (+1-201971-6302)